| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2020 | Aselage Steve80 | Director | Sell | 2,500 | $15.88 | $39,700.00 | -1.0% | |
| Mar 10, 2020 | Rote William E.58 | Senior Vice President, R&D | Sell | 3,250 | $14.87 | $48,327.50 | -11.2% | |
| Mar 10, 2020 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 3,500 | $15.02 | $52,570.00 | -11.5% | |
| Mar 10, 2020 | Clague Laura64 | Chief Financial Officer | Sell | 4,000 | $15.02 | $60,080.00 | -15.1% | |
| Mar 5, 2020 | Rosenberg Noah L. | Chief Medical Officer | Sell | 1,790 | $15.36 | $27,487.24 | -6.2% | |
| Mar 5, 2020 | Aselage Steve80 | Director | Sell | 4,359 | $15.36 | $66,938.55 | -1.7% | |
| Feb 18, 2020 | Rote William E.58 | Senior Vice President, R&D | Sell | 2,500 | $16.64 | $41,587.50 | -4.5% | |
| Feb 5, 2020 | Aselage Steve80 | Director | Sell | 2,500 | $16.62 | $41,550.00 | -1.0% | |
| Jan 8, 2020 | Dube Eric M57 | Chief Executive Officer | Sell | 7,500 | $14.54 | $109,050.00 | -7.8% | |
| Jan 8, 2020 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 1,500 | $14.54 | $21,810.00 | -3.9% |